DIAGNOS Inc. (DGNOF)
DIAGNOS Inc. operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in Brossard, QC, CA. The stock last traded at $0.35, up 5.26% on the session, giving a market capitalisation of $42.1M. On trailing twelve-month figures it carries a trailing P/E of -11.86, a net margin of -6956.8%. Its beta of -0.15 implies it has historically moved less than the broad market.
DIAGNOS Inc. specializes in delivering technology-driven services, with its reach primarily extending across Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. A cornerstone of its offerings is Computer Assisted Retina Analysis (CARA), a web-based software application in the healthcare sector. This innovative tool is designed to aid medical professionals in identifying diabetic retinopathy, empowering eye care specialists to clearly visualize both normal anatomical features of the retina and any disease-related changes. Beyond its medical applications, the company also furnishes expert consulting services in the domains of data analytics and artificial intelligence. Established in 1998, DIAGNOS maintains its principal office in Brossard, Canada.
DIAGNOS Inc. is most often compared with the following Healthcare names: